Plain-English translation of NCT06338072 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →This study is looking at how the Minimed 780G—an advanced automatic insulin pump—responds to the natural changes in insulin sensitivity that happen during a woman's menstrual cycle. Researchers want to understand how well the pump adjusts on its own during different phases of the cycle, and how they can make the system even smarter at keeping blood sugar steady.
Women with type 1 diabetes often find that their insulin needs change throughout their menstrual cycle, making blood sugar harder to control at certain times of the month. This trial exists to understand exactly how this medication responds to those changes, so the pump's automatic algorithms can be improved to better support women's unique needs.
You likely qualify if…
You likely don't qualify if…
You would continue wearing your Minimed 780G pump as normal while researchers monitor how well it controls your blood sugar across different phases of your menstrual cycle. About half of participants will also wear a small wearable device on their wrist that tracks temperature, heart rate, and movement to help identify cycle patterns. The study involves visits to the research center where you'll share information about your cycle and blood sugar data.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Spain
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborators
Universitat Politècnica de València
Enrollment target
~119 participants
Started
March 2024
Primary completion
November 2026
Age range
18 Years – 50 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lía Nattero-Chávez, MD.PhD
Diabetes, Obesity and Human Reproduction Research Group (IRYCIS)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.